NCT07484971 2026-04-17
CLIQQC
Société Algérienne de Formation et Recherche en Oncologie
Recruiting
Clinical Trials
43 trialsNCT06592924 2026-04-14
TRIPLE-SWITCH
Canadian Cancer Trials Group
Phase 3 Recruiting
NCT06801236 2026-04-09
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Acerand Therapeutics Limited
Phase 1 Recruiting
NCT07516886 2026-04-08
PPSARP
Lithuanian University of Health Sciences
Recruiting
NCT07124000 2026-03-31
DP-04
AstraZeneca
Recruiting
NCT05328505 2026-03-24
MIDAS-Prostate
University Health Network, Toronto
Phase NA Recruiting
NCT07426055 2026-03-23
PRO-BOOST-LC
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Recruiting
NCT07332000 2026-03-20
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Candel Therapeutics, Inc.
Phase 2 Recruiting
NCT06957691 2026-03-09
Fezo-ADT
Brigham and Women's Hospital
Phase 2 Recruiting
NCT07182279 2026-03-09
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
The Methodist Hospital Research Institute
Phase 1/2 Recruiting
NCT05873686 2026-03-03
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Nuvectis Pharma, Inc.
Phase 1 Recruiting
NCT06616597 2026-02-19
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT07115914 2026-02-17
PSMA PET for Surveillance After Focal Therapy
University of Chicago
Phase NA Recruiting
NCT07407608 2026-02-12
ABRUPT 2
University of Milano Bicocca
Recruiting
NCT06834152 2026-02-09
X-SMILE
University of Zurich
Recruiting
NCT07196488 2026-02-09
Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
National Taipei University of Nursing and Health Sciences
Phase NA Recruiting
NCT07391982 2026-02-06
DESTINATION 2
The Netherlands Cancer Institute
Phase NA Recruiting
NCT06631521 2026-02-05
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
AdventHealth
Phase 1 Recruiting
NCT07370597 2026-01-27
LUDOPATH
Jules Bordet Institute
Recruiting
NCT07363382 2026-01-23
The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer
First Affiliated Hospital of Fujian Medical University
Phase 1/2 Recruiting
NCT07344844 2026-01-15
SPAR
Clinique Sainte Clotilde
Phase NA Recruiting
NCT07339943 2026-01-14
MicroUSgFLA
University Health Network, Toronto
Phase NA Recruiting
NCT07129551 2026-01-12
NICE-PSMA
Martini-Klinik am UKE GmbH
Phase NA Recruiting
NCT06046131 2025-11-17
KP-CARAIBES
Centre Hospitalier Universitaire de la Guadeloupe
Phase NA Recruiting
NCT06862856 2025-11-13
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Massachusetts General Hospital
Recruiting
NCT06844383 2025-10-29
TALENT
Prostate Cancer Clinical Trials Consortium
Phase 2 Recruiting
NCT07219303 2025-10-29
DE-CART
Fox Chase Cancer Center
Phase NA Recruiting
NCT06800313 2025-10-16
A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Halda Therapeutics OpCo, Inc.
Phase 1/2 Recruiting
NCT07209865 2025-10-07
68Ga-P16-093 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
First Affiliated Hospital of Fujian Medical University
Phase 1/2 Recruiting
NCT07209878 2025-10-07
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
First Affiliated Hospital of Fujian Medical University
Phase 2/3 Recruiting
NCT07179783 2025-09-18
Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)
Tianjin Medical University Second Hospital
Phase 2 Recruiting
NCT04545957 2025-07-28
JUMP
Brigham and Women's Hospital
Phase NA Recruiting
NCT05574647 2025-07-24
IP7-PACIFIC
Imperial College London
Phase NA Recruiting
NCT07047495 2025-07-02
MINIONS
European Institute of Oncology
Recruiting
NCT07038304 2025-06-26
OLYMPIAN
University Medical Center Groningen
Phase 2 Recruiting
NCT06926374 2025-04-16
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Chinese University of Hong Kong
Phase NA Recruiting
NCT06822036 2025-02-17
ARISTA
St. Antonius Hospital Gronau
Phase NA Recruiting
NCT06820333 2025-02-11
Impact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer
Heinrich-Heine University, Duesseldorf
Recruiting
NCT06774781 2025-01-14
Assessment of ADC Values and Radiomics Characteristics With a MRI of the Prostate to Identify Tumor Lesions
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Recruiting
NCT06661044 2024-12-19
EVENTIDE
University of Aberdeen
Recruiting
NCT06665932 2024-11-12
Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins
University Hospital Ostrava
Phase NA Recruiting
NCT06636682 2024-10-21
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Cellvax Therapeutics Inc
Phase 2 Recruiting
NCT06612580 2024-09-25
68Ga-AAZTA-NI-093 PET/CT: First-in-human Study
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting